B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes

Clinical trial NCT03327571 · COMPLETED

Trial details

NCT number: NCT03327571
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Classical Hodgkin Lymphoma Relapsed or Refractory Classical Hodgkin Lymphoma

Start date: 2017-11-21
Primary completion: 2019-10-31
Enrollment: 1770

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.